Leveraging the Emergency Department (LEAD) Study

Launched by HACKENSACK MERIDIAN HEALTH · Sep 18, 2024

Keywords

ClinConnect Summary

The LEAD Study is a research trial aimed at improving lung cancer screening for patients who may be at risk. It takes place in the Emergency Department (ED) and uses a special tool that helps doctors identify patients who qualify for lung cancer screening based on their health and lifestyle. The study will first look at how many patients are reached and informed about lung screening. Then, it will test a tailored program designed to help these patients understand the importance of screening and address any barriers they might face, such as lack of knowledge or fear.

To participate in this study, individuals must be between 50 and 80 years old, currently smoke or have quit in the last 15 years with a significant smoking history, and have never been screened for lung cancer before. Participants will receive information about lung cancer screening and may be part of a program aimed at increasing their understanding and willingness to get screened. This trial is currently recruiting and welcomes all genders. It's an excellent opportunity for those who qualify to contribute to important research that could help many others at risk for lung cancer.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged 50 years to 80 years
• • Currently smoke cigarettes or quit smoking cigarettes within the past 15 years
• • 20 pack-year smoking history
• • Has never had lung cancer screening
• • Able to provide informed consent
• • Able to speak and understand English
• Exclusion Criteria:
• • Diagnosed with lung cancer
• • Has a history of having a lung cancer screening scan
• • Unable to speak and understand English